...
首页> 外文期刊>The Lancet >Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children.
【24h】

Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children.

机译:IL12B启动子多态性与儿童特应性和非特应性哮喘严重程度的关系。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Severe asthma is a frequent cause of hospital admission, especially among children. The main environmental triggers of airway inflammation in asthma are viruses and aeroallergens. These agents elicit reciprocal immune responses, characterised by production of T helper 1 and T helper 2 cytokines, respectively. There is no genetic explanation for how hyper-responsiveness to these disparate environmental stimuli develops among individuals with asthma. Our aim was to assess relation between an IL12B promoter polymorphism and asthma. METHODS: We did a cohort study in which we initially genotyped 411 6-year olds for the IL12B promoter polymorphism. We then assessed the relation between this polymorphism and asthma severity. A further 85 asthmatic children in an additional sample of 433 children from the same cohort were then assessed to confirm these findings. We also examined in-vitro interleukin-12 responses in a subgroup of individuals. FINDINGS: Heterozygosity for the IL12B promoter polymorphism was observed in 76% (16) of atopic and non-atopic individuals with severe asthma in the initial sample. By comparison, heterozygotes comprised only 31% (17) of the moderate asthma group, and 48% (20) of individuals with mild asthma were heterozygous, as were unaffected controls. These findings were confirmed in the second sample (overall p<0.0001). Our data suggest that IL12B promoter heterozygosity contributes to asthma severity rather than susceptibility per se. The severity-predisposing genotype was associated with reduced interleukin 12 p40 gene transcription and decreased interleukin 12 p70 secretion. INTERPRETATION: Interleukin 12 plays a key part in antagonism of T helper 2 differentiation, and in induction of antiviral host defense. Genetically determined attenuation of interleukin-12 response capacity would, therefore, provide a plausible common immunological pathway to disease severity for the two major forms of asthma.
机译:背景:严重哮喘是住院的常见原因,尤其是在儿童中。哮喘中气道炎症的主要环境诱因是病毒和气变应原。这些试剂引起相互的免疫反应,其特征是分别产生T辅助细胞1和T辅助细胞2。没有遗传学解释说明哮喘个体之间对这些不同的环境刺激的反应过度。我们的目的是评估IL12B启动子多态性与哮喘之间的关系。方法:我们进行了一项队列研究,最初我们对411名6岁的儿童进行了IL12B启动子多态性基因分型。然后,我们评估了这种多态性与哮喘严重程度之间的关系。然后评估来自同一队列的433名儿童的另外85名哮喘儿童,以证实这些发现。我们还检查了个体亚组中的体外白介素12反应。结果:在初始样本中,患有重度哮喘的特应性和非特应性个体中有76%(16)观察到IL12B启动子多态性的杂合性。相比之下,杂合子仅占中度哮喘组的31%(17),轻度哮喘患者中有48%(20)属于杂合子,而未受影响的对照组也是如此。这些发现在第二个样本中得到了证实(总体p <0.0001)。我们的数据表明,IL12B启动子杂合性有助于哮喘的严重程度,而不是易感性。严重程度高的基因型与白介素12 p40基因转录减少和白介素12 p70分泌减少有关。解释:白介素12在T辅助2分化的拮抗作用和抗病毒宿主防御的诱导中起关键作用。因此,遗传学上确定的白细胞介素12反应能力的减弱将为两种主要形式的哮喘提供一种可能的常见免疫学途径,用于疾病严重程度的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号